Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin
European Respiratory Journal · 2026-05 · 67 (5) · 2600143
DOI: 10.1183/13993003.00143-2026 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 07.05.2026. Verfasst von Christiane Whetstone und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, ON, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: GlaxoSmithKline.
Abstract (Originalsprache)
Extract Reply to W. Zhan and co-workers: The recently published MUCOSA trial in the European Respiratory Journal, which evaluated the effects of mepolizumab on objective cough frequency in patients with refractory chronic cough (RCC), has prompted a re-evaluation of the role of eosinophils in cough pathophysiology [1].
Autor:innen und Institutionen
- Department of Medicine, McMaster University, Hamilton, ON, Canada.
- Department of Medicine and Research Institute of the McGill University Health System, McGill University, Montreal, QC, Canada.
- Department of Medicine, University of Calgary, Calgary, AB, Canada.
- Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
- Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton, ON, Canada.
- Department of Medicine, McMaster University, Hamilton, ON, Canada satiai@mcmaster.ca.
ORCID-Profile: Mustafaa Wahab, Wafa Hassan, Kimberley Holt, Roma Sehmi, Jaclyn A Smith, Paul M O'Byrne, Imran Satia, Gail M Gauvreau
Förderung
- GlaxoSmithKline
Zitieren
APA
Whetstone, C., Diab, N., Brister, D., Kum, E., Wahab, M., Hassan, W., Beaudin, S., Obminski, C., Wattie, J., Wiltshire, L., Howie, K., Killian, K., Holt, K., Sehmi, R., Smith, J. A., O'Byrne, P. M., Satia, I., & Gauvreau, G. M. (2026). Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin. European Respiratory Journal, 67(5), 2600143. https://doi.org/10.1183/13993003.00143-2026
Vancouver
Whetstone C, Diab N, Brister D, Kum E, Wahab M, Hassan W, et al. Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin. European Respiratory Journal. 2026;67(5):2600143. doi:10.1183/13993003.00143-2026
BibTeX
@article{Whetstone2026,
author = {Whetstone, Christiane and Diab, Nermin and Brister, Danica and Kum, Elena and Wahab, Mustafaa and Hassan, Wafa and Beaudin, Sue and Obminski, Catie and Wattie, Jennifer and Wiltshire, Lesley and Howie, Karen and Killian, Kieran and Holt, Kimberley and Sehmi, Roma and Smith, Jaclyn A and O'Byrne, Paul M and Satia, Imran and Gauvreau, Gail M},
title = {Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {5},
pages = {2600143},
doi = {10.1183/13993003.00143-2026}
}
EUVIMED